Company Filing History:
1 out of 1 
1 out of 1 
1 out of 832,912 Years Active: 2014-2018
Title: Wanxiang Xu: Innovator in Human Papillomavirus Research
Introduction
Wanxiang Xu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of human papillomavirus (HPV) research, particularly in the development of peptide-based vaccines and diagnostic tools. With a total of 2 patents, his work focuses on identifying and utilizing specific epitopes to enhance immunological responses against HPV.
Latest Patents
Wanxiang Xu's latest patents include groundbreaking inventions that target the E6 protein of HPV. The first patent, titled "Fine epitope peptide capable of inducing cross-reactive antibodies among homologous proteins in human papilloma virus E6 protein," describes a minimal motif of an epitope on the E6 protein. This epitope induces a monoclonal antibody that exhibits cross-reactivity with several homologous proteins of high-risk HPVs, including HPV16, 33, 52, and 58. The peptides derived from this epitope can be utilized to create immunogens or serological detection antigens against HPV E6 proteins, as well as to develop universal antibodies for various high-risk HPV types.
The second patent, "Minimal motifs of linear B-cell epitopes in L1 protein from human papillomavirus type 58 and their applications," discloses eighteen linear epitope motifs and their extended 8-mer peptides in the L1 protein from HPV 58. These motifs can serve as antigens for detecting serum from subjects infected with HPV 58 or for developing multi-epitope peptide vaccines aimed at inducing humoral immunity against HPV 58. Among the eighteen motifs, ten are 100% conservative, making them strong candidates for universal epitope development in preventive or therapeutic HPV vaccines.
Career Highlights
Throughout his career, Wanxiang Xu has worked with various organizations, including Guangdong Nanwan Pharmaceutical Technology Co. Ltd. His expertise in peptide design and immunology has positioned him as a key figure in HPV research and vaccine development.
Collaborations
Wanxiang Xu has collaborated with notable professionals in the field, including Riting Liu and Shaohua Gu. These partnerships have furthered his research and contributed to advancements in HPV-related innovations.
Conclusion
Wanxiang Xu's contributions to HPV research through his innovative patents and collaborations highlight his role as a leading inventor